The primary objective of the proposed study is to evaluate the safety and efficacy of
Brexpiprazole in adults with borderline personality disorder (BPD). The hypothesis to be
tested is that brexpiprazole will be more effective and well tolerated in adults with BPD
compared to placebo. The proposed study will provide needed data on the treatment of a
disabling disorder.